Efflux of glutathione and glutathione complexes from human erythrocytes in response to inorganic arsenic exposure

Biological Trace Element Research

Volumn 150, Issue 1-3, 2012, Pages 451-459

  Yildiz, Deniz ^a   Cakir, Yeliz ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Arsenite; Erythrocytes; Glutathione efflux

Indexed keywords

ARSENATE SODIUM; ARSENITE SODIUM; CARRIER PROTEIN; GLUTATHIONE; GLUTATHIONE COMPLEX; LACTATE DEHYDROGENASE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANT ASSOCIATED PROTEIN 1; PROTEIN INHIBITOR; SUCCIMER; THIOL; UNCLASSIFIED DRUG; VERAPAMIL; VERLUKAST;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; ERYTHROCYTE; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; PROTEIN TRANSPORT; SUPERNATANT;

ARSENATES; ARSENICALS; ARSENITES; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CHELATING AGENTS; CULTURE MEDIA, CONDITIONED; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; GLUTATHIONE; HUMANS; MEMBRANE TRANSPORT MODULATORS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; P-GLYCOPROTEIN; SODIUM COMPOUNDS; SULFHYDRYL COMPOUNDS; TEMPERATURE;

EID: 84870654333     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9491-9     Document Type: Article

References (48)

1. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JSN, Huang CH, Chen CJ (1995) Incidence of internal cancers and ingested inorganic arsenic: a 7-year follow-up study in Taiwan. Cancer Res 55:1296-1300
2. Das D, Chatterjee A, Mandal BK, Samanta G, Chakraborti D (1995) Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 120:917-924
3. Kersjes MP, Maurer JR, Trestrail JH, McCoy DJ (1987) An analysis of arsenic exposures referred to the blodgett regional poison center. Vet Hum Toxicol 29:75-78
4. Kelafant GA, Kasarskis EJ, Horstman SW, Cohen C, Frank AL (1993) Arsenic poisoning in central Kentucky: a case report. Am J Ind Med 24:723-726
5. Kingston RL, Hall S, Sioris L (1993) Clinical observations and medical outcome in 149 cases of arsenate ant killer ingestion. Clin Toxicol 31:581-591
6. Ishinishi N, Tsuchiya K, Vahter M, Fowler BA (1986) Arsenic. In: Friberg L, Nordberg GF, Vouk V (eds) Handbook on the toxicology of metals, 2nd edn. Elsevier Science, New York, pp 43-83
7. Iffland R (1994) Arsenic. In: Seiler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Marcel Dekker, New York, pp 237-253
8. Chan PC, Huff J (1997) Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcino Ecotox Rev C15:83
9. Knowles FC, Benson AA (1983) The biochemistry of arsenic. Trends Biochem Sci 8:178-180
10. Dixon HBF (1977) The biochemical action of arsonic acids, especially as phosphate analogues. Adv Inorg Chem 44:191-227
11. Hughes MF (2002) Arsenic toxicity and potential mechanisms of action. Toxicol Letters 133(1):1-16
12. Nordenson I, Beckman L (1991) Is the genotoxic effect of arsenic mediated by oxygen free radicals. Hum Heredity 41:71-73
13. Shi H, Hudson LG, Ding W, Wang S, Cooper KL, Liu S, Chen Y, Shi X, Liu KJ (2004) Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol 17(7):871-878
14. Ding W, Hudson LG, Liu KJ (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 279(1-2):105-112
15. Lantz CR, Hays AM (2006) Role of oxidative stress in arsenic-induced toxicity. Drug Metabolism Reviews 38(4):791-804
16. Winski SL, Carter DE (1995) Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J Toxicol Environ Health 46(3):379-397
17. Loe DW, Deeley RG, Cole SPC (1998) Characterization of vincristine transport by the Mr 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 58:5130-5136
18. Musallam L, Ethier C, Haddad PS, Denizeau F, Bilodeau M (2002) Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am J Physiol Gastrointest Liver Physiol 283:G709-G718
19. Pullar JM, Hampton MB (2002) Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J Biol Chem 277(22):19402-19407
20. He YY, Huang JL, Ramirez DC, Chignell CF (2003) Role of reduced glutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA. J Biol Chem 278(10):8058-8064
21. Franco R, Cidlowski JA (2006) SLCO/OATP-like transport of glutathione in FasL-induced apoptosis. glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem 281(40):29542-29557
22. Rothnie A, Callaghan R, Deeley RG, Cole SPC (2006) Role of GSH in estrone sulfate binding and translocation by the multidrug resistance protein 1 (MRP1/ABCC1). J Biol Chem 281(20):13906-13914
23. Winski SL, Carter DE (1998) Arsenate toxicity in human erythrocytes: characterization of morphologic changes and determination of the mechanism of damage. J Toxicol Environ Health A 53(5):345-355
24. Zhanga TL, Gaob YX, Luc JF, Wang K (2000) Arsenite, arsenate and vanadate affect human erythrocyte membrane. J Inorganic Biochem 79(1-4):195-203
25. Nemeti B, Csanaky I, Gregus Z (2003) Arsenate reduction in human erythrocytes and rats-testing the role of purine nucleoside phosphorylase. Toxicol Sci 74:22-31
26. Sedlak J, Lindsay RH (1963) Determination of sulfhydryl groups in biological samples. Analytical Biochem 25:192-205
27. Welder AA, Acosta D (1994) Enzyme leakage as an indicator of cytotoxicity in cultured cells. Meth Toxicol 18:46-49
28. Leslie EM, Haimeur A, Waalkes MP (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. Biol Chem 279(31):32700-32708
29. Delnomdedieu M, Basti MM, Otvos JD, Thomas DJ (1993) Transfer of arsenite from glutathione to dithiols: a model of interaction. Chem Res Toxicol 6(5):598-602
30. Csanaky I, Gregus Z (2001) Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicol Sci 63:29-36
31. Gyurasics A, Varga F, Gregus Z (1991) Glutathione-dependent biliary excretion of arsenic. Biochem Pharmacol 42(3):465-468
32. Nemeti B, Gregus Z (2005) Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol-characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis. Toxicol Sci 85(2):847-858
33. Braman RS, Foreback CC (1973) Methylated forms of arsenic in the environment. Science 182(4118):1247-1249
34. Aposhian HV, Gurzau ES, Le XC et al (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13(8):693-697
35. Mandal BK, Ogra Y, Suzuki KT (2001) Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14(4):371-378
36. Kala SV, Neely MW, Kala G et al (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275(43):33404-33408
37. Suzuki KT, Tomita T, Ogra Y, Ohmichi M (2001) Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem Res Toxicol 14(12):1604-1611
38. Hayakawa T, Kobayashi Y, Cui X, Hirano S (2005) A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79(4):183-191
39. Naranmandura H, Suzuki N, Suzuki KT (2006) Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 19(8):1010-1018
40. Kondo T, Dale GL, Beutler E (1980) Glutathione transport by inside-out vesicles from human erythrocytes. Proc Natl Acad Sci USA 77(11):6359-6362
41. Anundi I, Hogberg J, Vahter M (1982) GSH release in bile as influenced by arsenite. FEBS Lett 145(2):285-288
42. Zaman GJR, Lankelma J, Tellingen OV, Beijnens J, Dekker H, Paulusma C, Ronald PJ, Elferink O, Baas F, Brost P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694
43. Huang RN, Lee TC (1996) Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant chinese hamster ovary cells. Toxicol Appl Pharmacol 141(1):17-22
44. Delnomendieu M, Basti MM, Styblo M, Otvos JD, Thomas DJ (1994) Complexation of arsenic species in rabbit erythrocytes. Chem Res Toxicol 7:621-627
45. Abraham EH, Sterling KM, Kim RJ, Salikhova AY, Huffman HB, Crockett MA, Johnston N, Parker HW, Boyle WE Jr, Hartov A, Demidenko E, Efird J, Kahn J, Grubman SA, Jefferson DM, Robson SC, Thakar JH, Lorico A, Rappa G, Sartorell AC, Okunieff P (2001) Erythrocyte membrane ATP Binding Cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (Ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cell Mol Dis 27(1):165-180
46. Klokouzas A, Wu CP, Van Veen HW, Barnard MA, Hladky SB (2003) cGMP and glutathione-conjugate transport in human erythrocytes. The roles of the multidrug resistance-associated proteins, MRP1, MRP4 and MRP5. Eur J Biochem 270:3696-3708
47. Abraham EH, Shrivastav B, Salikhova AY, Sterling KM, Johnston N, Guidotti G, Scala S, Litman T, Chan KC, Arceci RJ, Steiglitz K, Herscher L, Okunieff P (2001) Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cell Mol Dis 27(1):181-200
48. Salerno M, Petroutsa M, Suillerot AG (2002) The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation. J Bioenerg Biomembr 34(2):135-145